Contract Notice Pharmaceutical ProductsOpenhouse Finished Medicinal Products In Oncology Parenteral Preparations Description The Subject Of The Publication Is The Conclusion Of Non Exclusive Agreements Under 130A Abs 8A Sgb V In The Context Of A Cross Fund Open House Process For Various Pharmaceutical Active Ingredients For Parenteral Preparations Prepared From Pharmaceuticals In Oncology For Direct Medical Use The Contracts Can Be Concluded At Any Time For The Kv Regions Nordrhein Westfalen Lippe Schleswig Holstein And Hamburg Pharmacies In The Above Mentioned Kv Regions Are Obliged To Use The Products Of The Contracting Partner For The Production Of Preparations Because Of The Economic Efficiency Requirement The Aok Rheinland Hamburg Carries Out The Procedure In The Name Of All Funds Listed In Annex 2 Of The Discount Agreements Contracts With Fixed Conditions Are Offered For The Following Active Substances L01xx02 Asparaginase E Coli L01xx02 Asparaginase Erwinia Chrysanthemi L01bc07 AzacitidineL01aa09 BendamustinL01dc01 BleomycinL01xx32 BortezomibV03af03 Calcium FolinateL01xa02 CarboplatinL01xc06 CetuximabL01xa01 CisplatinL01bb04 CladribineL01aa01 CyclophosphamideL01bc01 CytarabineL01bc01 Cytarabine LiposomalL01ax04 DacarbazineL01da01 DactinomycinL01db02 DaunorubicinV03af02 DexrazoxaneV03af06 Disodium FolinateL01cd02 DocetaxelL01db01 DoxorubicinL01db01 Doxorubicin Liposome EncapsulatedL01db01 Doxorubicin Peg LiposomalL01db03 EpirubicinL01cb01 EtoposideL01bb05 FludarabinL01bc02 FluorouracilL01bc05 GemcitabineL01db06 IdarubicinL01aa06 IfosfamideL01xx19 IrinotecanL01xx19 Irinotecan Peg LiposomalL01aa03 MelphalanV03af01 MesnaL01ba01 MethotrexateL01db07 MitoxantroneL01xc10 OfatumumabL01xa03 OxaliplatinL01cd01 PaclitaxelL01cd01 Paclitaxel Human Serum Albumin Bound NanoparticlesL01xc08 PanitumumabL01xx24 Pegaspargase E Coli L01ba04 PemetrexedL01xx08 PentostatinL01ax03 TemozolomideL01xe09 TemsirolimusL01ac01 ThiotepaL01xx17 TopotecanL01cx01 TrabectedinL01ab02 TreosulfanL01ca01 VinblastineL01ca02 VincristineL01ca03 VindesinL01ca05 VinflunineL01ca04 VinorelbinTime Limit For Receipt Of Tenders Or Requests To Participate Date 01 08 2019 Local Time 12 00 Disclaimer The Above Text Is Machine Translated For Accurate Information Kindly Refer The Original Document
Contact Information
Other Detail
View Notice Now...
Fill Detail for Getting Instant Access
Download Tender Document / Tender Notice
Dear Sir,
Warm Greetings from TenderDetail.com !!
We have received Tender Document request for the TDR No : 17451963
Tender Notice along with it's Attachments ( Tender Document / Scan Image of News Paper)
sent to your Email Address :.
Please check your email for Tender Document.